Advertisement

Topics

VISTAKON, Division of Johnson & Johnson Vision Care, Inc. Company Profile

01:02 EST 25th November 2017 | BioPortfolio


News Articles [2616 Associated News Articles listed on BioPortfolio]

Johnson & Johnson Vision focused on lifetime of eye care

Thomas G. FrinziDuring the European Society of Cataract and Refractive Surgeons meeting in Lisbon, Portugal, Ocular Surgery News spoke with Thomas G. Frinzi, worldwide president, surgical, at Johnson ...

Johnson & Johnson Vision to acquire TearScience

Johnson & Johnson Vision announced it will acquire TearScience through Abbott Medical Optics, its surgical vision operating company, according to a company press release.Financial terms of the acquisi...

VIDEO: Two new products launched by Johnson & Johnson Vision at ESCRS

LISBON, Portugal — In this video, Thomas G. Frinzi, worldwide president, surgical, Johnson & Johnson Vision, talks about two new products launched at the European Society of Cataract and Refractive ...

J&J Vision Care scoops up TearScience

Johnson & Johnson Vision Care Inc. is buying ophthalmologic device maker TearScience Inc. for an undisclosed sum.

Johnson & Johnson Vision Care, Inc. to Acquire TearScience, Inc.

  Life Sciences Jobs   ...

VIDEO: J&J Vision marks milestones, new innovations

NEW ORLEANS ― At the Ophthalmology Innovation Summit here, Tom Frinzi, global president of surgical at Johnson & Johnson Vision Care, discusses new milestones with the Tecnis Symfony and Symfony tor...

Johnson & Johnson Vision completes TearScience acquisition

Johnson & Johnson Vision’s acquisition of TearScience has been completed, according to a company press release.The company announced in August that it would acquire TearScience, which has FDA cleara...

Johnson & Johnson Posting Notable Gain After Upgrade By Jefferies

NEW BRUNSWICK (dpa-AFX) - Shares of Johnson & Johnson (JNJ) have shown a notable move to the upside during trading on Wednesday, climbing by 2 percent. With the upward move, Johnson & Johnson has ...

PubMed Articles [4414 Associated PubMed Articles listed on BioPortfolio]

Cefepime Associated With Phenytoin Induced Stevens-Johnson Syndrome.

We describe a recent case of Stevens-Johnson Syndrome. A 49-year-old man was admitted to the Intensive Care Unit of an Anaesthesia and Resuscitation Department because of a Fournier gangrene that deri...

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Associations, Outcomes, and Pathobiology-Thirty Years of Progress but Still Much to Be Done.

Although rare, Stevens-Johnson syndrome and toxic epidermal necrolysis remain among the most devastating of acute conditions involving the skin. In the past 30 years, tremendous progress has been made...

Are steroids effective in toxic epidermal necrolysis and Stevens-Johnson syndrome?

Toxic epidermal necrolysis and Stevens-Johnson syndrome are severe adverse skin reactions to medications and infections. Steroids are described as a therapeutic alternative, but their use is still con...

Stevens-Johnson syndrome and toxic epidermal necrolysis: epidemiological and clinical outcomes analysis in public hospitals.

Adverse drug reactions are harmful and involuntary responses to drugs that occur at doses normally used for a given condition. Among them are Stevens-Johnson syndrome and toxic epidermal necrolysis, b...

Role of Scleral Contact Lenses in Management of Coexisting Keratoconus and Stevens-Johnson Syndrome.

To report the rare coexistence of keratoconus and Stevens-Johnson syndrome (SJS) managed with scleral contact lenses (ScCLs).

Clinical Trials [4197 Associated Clinical Trials listed on BioPortfolio]

Stevens-Johnson Syndrome Antimicrobial

Steven-Johnson's syndrome, or great multiform erythema, appears as a systemic disturbance, with skin involvement and mucous membranes, related to several factors, such as, viral or bacteri...

Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.

Patients diagnosed with Stevens-Johnson syndrome and Toxic Epidermal Necrolysis were confirmed based on the investigators national diagnostic criteria. Patients who meet all inclusion crit...

Contact Lens in Pediatrics (CLIP) in an Asian Population Study

To evaluate the safety, efficacy and physiological performance of daily disposable spherical and toric soft contact lenses in a vision-corrected population of children ages 8-11 years of a...

Extracorporeal Photopheresis Pilot Study

ECP will be given to the patients [UVAR®XTS TM Therakos system, Johnson & Johnson] according to the following schedule: Starting at day 21 after transplant, if hematologic recovery allow...

A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fed Condition

The study was conducted as an open-label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioavailability study comparing famotidine tablets, USP 20 ...

Companies [3437 Associated Companies listed on BioPortfolio]

Vistakon, a division of Johnson & Johnson Vision Care, Inc.

SOURCE Vistakon, a division of Johnson & Johnson Vision Care, Inc.

VISTAKON(R), Division of Johnson & Johnson Vision Care, Inc.

VISTAKON, Division of Johnson & Johnson Vision Care, Inc.

Johnson and Johnson

Johnson & Johnson, employing approximately 119,000 people worldwide, is engaged in the manufacture and sale of a broad range of products in the health care field in many countries of the world. Johnso...

JOHNSON'S(R) Brand

JOHNSON'S® Brand from Johnson & Johnson Consumer Products Company, Division of Johnson & Johnson Consumer Companies, Inc., has a long tradition of providing pure, mild, gentle and clinically-proven p...

More Information about "VISTAKON, Division of Johnson & Johnson Vision Care, Inc." on BioPortfolio

We have published hundreds of VISTAKON, Division of Johnson & Johnson Vision Care, Inc. news stories on BioPortfolio along with dozens of VISTAKON, Division of Johnson & Johnson Vision Care, Inc. Clinical Trials and PubMed Articles about VISTAKON, Division of Johnson & Johnson Vision Care, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of VISTAKON, Division of Johnson & Johnson Vision Care, Inc. Companies in our database. You can also find out about relevant VISTAKON, Division of Johnson & Johnson Vision Care, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record